$0.25
▲ +1.2% Today
as of Jul 22, 16:45 ET
Last 30 days
Recent Press Releases & News
AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program
AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series
Overview
52-week range
$0.21
$20
0% of range
Avg surprise (last 2)
+45.1%
Avg reaction (last 1)
-3.8%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-0.69 | $-1.08 | +36.1% | — | -3.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $1.57 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-3.68 | $8.00 | +54.0% | — | — | earnings |
| Mon Mar 31, 2025 | Mar 2025 | $-0.05 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-6.00 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-3.00 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.12 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.16 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.10 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | -$0.12 | -$3.68 | +96.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22,000 | — | $26,000 | $25,000 | $16,000 | — | $35,000 | $50,000 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-2M | — | $-2M | $-3M | $-4M | — | $-4M | $-4M |
| Net income | $-3M | — | $-3M | $-3M | $-4M | — | $-4M | $-2M |
| EPS (diluted) | $-0.69 | — | $1.57 | $-3.68 | $-0.05 | — | $-6.00 | $-3.00 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $6M | $3M | $2M | $476,000 | $898,000 | $2M | $915,000 | $4M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $6M | $3M | $3M | $1M | $3M | $4M | $8M | $10M |
| Total assets | $9M | $6M | $5M | $4M | $6M | $9M | $14M | $16M |
| Long-term debt | $210,000 | $927,000 | — | — | — | — | $139,000 | $283,000 |
| Total liabilities | $6M | $16M | $12M | $11M | $10M | $10M | $11M | $10M |
| Total equity | $2M | $-10M | $-6M | $-7M | $-4M | $-1M | $3M | $6M |
Implied volatility — last 90 days
No IV snapshots yet for AIM.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.